Litigation Details for CG Technology Development, LLC v. William Hill U.S. Holdco, Inc. (D. Del. 2018)
✉ Email this page to a colleague
CG Technology Development, LLC v. William Hill U.S. Holdco, Inc. (D. Del. 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-04-10 |
| Court | District Court, D. Delaware | Date Terminated | 2020-09-02 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | Plaintiff | Referred To | |
| Parties | BRANDYWINE BOOKMAKING LLC | ||
| Patents | 9,076,305 | ||
| Attorneys | Daniel M. Silver | ||
| Firms | Faegre Drinker Biddle & Reath LLP | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in CG Technology Development, LLC v. William Hill U.S. Holdco, Inc.
The biologic drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for CG Technology Development, LLC v. William Hill U.S. Holdco, Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-04-10 | 1 | Complaint | .S. Patent Nos. 9,240,098; 9,269,224; and 9,076,305 (collectively the “Patents-in-Suit”). …224 patent is attached as Exhibit B. 16. U.S. Patent No. 9,076,305 (“the… U.S. PATENT NO. 9,076,305 43. Determining accurate… COUNT III: INFRINGEMENT OF U.S. PATENT NO. 9,076,305 73. Plaintiff incorporates… THE PATENTS-IN-SUIT 14. U.S. Patent No. 9,240,098 (“the ’098 patent”), titled | External link to document |
| 2018-04-10 | 3 | Patent/Trademark Report to Commissioner | B2; US 9,269,224 B2; US 9,076,305 B2. (fms) (Entered: 04/10/2018) 10 April 2018 PACER Document… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,240,098 B2… 2 September 2020 1:18-cv-00533 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| 2019-08-28 | 67 | Memorandum and Order | quot;the ' 224 patent"), and 9,076,305 ("the ' 305 patent") relating to sports …U.S . Patent No. 9,875,608 ("the ' 608 patent"). (Id 1134-37). The ' 608 patent cites…asserting infringement of U.S. Patent Nos. 9,240,098 ("the ' 098 patent"), 9,269,224 ("…for infringement of U.S. Patent No. 10,096,207 ("the '207 patent"). (D.I. 35). Defendants…Section 101 Section 101 of the Patent Act defines patent-eligible subject matter. It provides: | External link to document |
| 2019-08-29 | 68 | Memorandum and Order | the ' 224 patent"), 10,096,207 ("the '207 patent"), and 9,076,305 ("the &…asserts infringement of U.S. Patent Nos. 9,240,098 ("the ' 098 patent"), 9,269,224 ("… ' 305 patent"). (D.I. 35). The PTAB instituted inter partes review ("IPR") proceedings… of the ' 098, ' 224, and ' 207 patents. (D.I. 66). I denied Defendants' motion to…dismiss Plaintiffs claims based on the ' 305 patent. (D.I. 67). The standard for granting a | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
